Trial Profile
Assessment of Surface Coverage of Polymer-based Sirolimus-eluting Stent (Cypher) or Polymer-free Paclitaxel-eluting Stent (YinYi ) in Diabetes Mellitus and Non- Diabetes Mellitus Patients by Optical Coherence Tomography.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms HMUOCT-DM-vs-NDM-2
- 07 Dec 2009 New trial record